Reducing cognitive errors in dermatology: Can anything be done? - 23/10/13
Abstract |
An increasing focus on the prevention of medical errors is a direct result of a growing patient safety movement. Although the reduction of technical errors has been the focus of most interventions, cognitive errors, usually more than one error linked together, actually cause the majority of misdiagnoses. This article examines the most common types of cognitive errors in dermatology. Two methods to minimize these errors are recommended: first, cognitive debiasing techniques reduce the common initiating factor of error cascades; and secondly, the application of prospective hindsight attacks the final common pathway that leads to misdiagnosis.
Le texte complet de cet article est disponible en PDF.Key words : cognitive science, diagnostic errors, differential diagnosis, patient safety, quality assurance
Plan
Funding sources: None. |
|
Disclosures: Dr Brodell is on the speaker's bureau of Allergan, Galderma, 3M/Graceway Pharmaceuticals, GlaxoSmithKline/Stiefel, Dermik, Novartis Pharmaceuticals Corp, Sanofi-Aventis, Medicis, and PharmaDerm, a division of Nycomed US Inc; is a consultant for Galderma Laboratories LP, Medicis, Dow Pharmaceuticals Sciences, and Promius; is on the advisory board of Dow Pharmaceuticals Sciences and Nycomed US Inc; and receives grant/research support from Galderma, Abbott Laboratories, and Dow Pharmaceuticals Sciences. Dr Helms declares research support from Galderma and Amgen. Mr Dunbar has no conflicts of interest to declare. |
Vol 69 - N° 5
P. 810-813 - novembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?